Log In
Print
BCIQ
Print
Print this Print this
 

Zuplenz, ondansetron

  Manage Alerts
Collapse Summary General Information
Company MonoSol Rx LLC
DescriptionSelective serotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationEmesis
Partner

Vestiq Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today